Page last updated: 2024-11-06

9,10-dicyanoanthracene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9,10-Dicyanoanthracene (DCA) is a fluorescent organic compound with a high electron affinity. It is commonly used as an electron acceptor in organic electronics, photochemistry, and as a sensitizer in dye-sensitized solar cells. DCA is synthesized through a multi-step process involving the reaction of anthracene with cyanuric chloride followed by hydrolysis and dechlorination. Its strong electron-withdrawing cyano groups contribute to its high electron affinity and efficient charge transfer properties. The ability of DCA to accept electrons facilitates its use in various applications such as organic light-emitting diodes (OLEDs), organic field-effect transistors (OFETs), and as a photosensitizer in organic photovoltaics. Researchers study DCA due to its potential in developing highly efficient and stable organic electronic devices. Its fluorescence properties and high electron affinity make it a promising material for advanced optoelectronic applications.'

9,10-dicyanoanthracene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

anthracene-9,10-dinitrile : An anthracenedinitrile carrying cyano groups at positions 9 and 10. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID71035
CHEBI ID51302
SCHEMBL ID150623
MeSH IDM0511579

Synonyms (29)

Synonym
HMS1579K10
9,10-dicyanoanthracen
anthracene-9,10-dicarbonitrile
CHEBI:51302
anthracene-9,10-dinitrile
9,10-anthracenedicarbonitrile
9,10-dicyanoanthracene
nsc-17556
nsc17556
1217-45-4
9,10-anthracenedicarbonitrile, 97%
AKOS003368402
D1656
A804779
nsc 17556
FT-0621596
SCHEMBL150623
DTXSID4061628
c16h8n2
J-004614
mfcd00041733
AS-59700
9,10-dicyanoanthracene, >/=98%
Q27122536
AMY3581
CS-0120011
T70149
SY052160
YSWG071
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
acene-9,10-dinitrileAny acene dinitrile carrying cyano groups at positions 9 and 10.
anthracenedinitrile
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.75 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index31.50 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]